Blame Flies at Capitol Hill Hearing on the Reasons for High-Priced Drugs

International Pharmaceutical Regulatory Monitor
A A
Finger-pointing abounded during a Senate hearing on prescription drug prices, where branded and generic industry representatives testified alongside pharmacy, wholesale distributor and benefit manager groups.

To View This Article:

Login

Subscribe To International Pharmaceutical Regulatory Monitor